Rectal disease undergoing laparoscopic rectal surgery with making diverting ileostomy
Conditions
Interventions
None listed
Sponsors
Minimally Invasive Surgical and Medical Oncology,Fukushima Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Patients with rectal cancer, ulcerative colitis, familial adenomatous polyposis(FAP) or rectal GIST. 2)Laparoscopic surgery (robot-assisted surgery is also possible) 3)Patients of low rectal anterior resection with diverting ileostomy 4)Performance Status (ECOG):0-2 5)Hematological, renal, and hepatic functions that meet the surgical criteria of each institution 6)Obtained written informed consent
Exclusion criteria
Exclusion criteria: 1)Patients of rectal cancer with intraoperative peritoneal dissemination or class V diagnosis by ascites cell diagnosis 2)Contaminated and infected surgical cases such as perforation and toxic megacolon 3)Surgery other than laparoscopic surgery such as laparotomy or transsacral surgery 4)Patients required conversion to open surgery or other simultaneous abdominal surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Outlet obstruction incidence from immediately after surgery to closure of Diverting ileostomy | — |
Secondary
| Measure | Time frame |
|---|---|
| From postoperative until discharge 1)Number of vomiting 2)Abdominal distention, degree of abdominal pain (evaluated by Numeric Rating Scale (NRS)) 3)Relationship between outlet obstruction and stoma emission | — |
Countries
Japan
Contacts
Public ContactYukitoshi Todate
Southern Tohoku General Hospital Surgical Oncology
Outcome results
None listed